Scarica l'app Stockscreener
27.90
8.73%
2.24
Dopo l'orario di chiusura:
27.90
Quidelortho Corporation Borsa (QDEL) Ultime notizie
QuidelOrtho's Strategic Leadership Reinforcement and Growth Potential: A Catalyst for Diagnostics Sector Transformation - AInvest
QuidelOrtho's Strategic Leadership Addition and Growth Potential: Leveraging Erich Wolff's Expertise for Inorganic Growth - AInvest
QuidelOrtho names Erich Wolff as EVP of strategy & corporate development - Investing.com
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development | QDEL Stock News - GuruFocus
Quidelortho welcomes Erich Wolff as EVP, strategy & corporate development - MarketScreener
QuidelOrtho Appoints Erich Wolff as Executive Vice President, Strategy & Corporate Development. - AInvest
QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development - Barchart.com
QuidelOrtho Corporation Recovers — But Is It Sustainable2025 Top Gainers & AI Enhanced Trade Execution Alerts - newsyoung.net
Multi Factor Analysis Ranks QuidelOrtho Corporation as Strong Buy2025 Top Decliners & Technical Buy Zone Confirmation - newsyoung.net
When is the best time to buy QuidelOrtho Corporation stockChart Signals & Consistent Profit Trading Strategies - beatles.ru
QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Fibonacci Retracement Aligns with Support in QuidelOrtho CorporationQuarterly Trade Report & Weekly Watchlist for Consistent Profits - sundaytimes.kr
QuidelOrtho launches certified analyser programme for rural health facilities - Yahoo Finance
QuidelOrtho Launches Certified Analyzer Program to Enhance Diagnostic Access in Rural Areas - AInvest
Is QuidelOrtho's (QDEL) Steadfast Revenue Outlook a Sign of Management Conviction or Overconfidence? - simplywall.st
Visual trend scoring systems applied to QuidelOrtho Corporation2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - Newser
Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know - MSN
QuidelOrtho launches certified analyzer program for rural healthcare - Investing.com
QuidelOrtho launches certified analyzer program for rural healthcare By Investing.com - Investing.com Nigeria
QuidelOrtho's Strategic Expansion in Point-of-Care Diagnostics: A Pathway to Long-Term Value Creation - AInvest
QuidelOrtho Launches Certified Analyzer Program | QDEL Stock News - GuruFocus
QuidelOrtho Launches Certified Analyzer Program to Expand Diagnostic Testing in Underserved Communities - AInvest
QuidelOrtho launches certified analyzer program for underserved areas - StreetInsider
QuidelOrtho Launches Certified Analyzer Program - WV News
The Top 5 Analyst Questions From QuidelOrtho’s Q2 Earnings Call - Yahoo Finance
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - Yahoo Finance
AI Tools Suggest QuidelOrtho Corporation May Outperform This WeekRisk Managed Intraday Trade Alerts Increase in Volume - 선데이타임즈
Earnings Release: Here's Why Analysts Cut Their QuidelOrtho Corporation (NASDAQ:QDEL) Price Target To US$43.14 - 富途牛牛
Published on: 2025-08-09 08:22:34 - beatles.ru
There's No Escaping QuidelOrtho Corporation's (NASDAQ:QDEL) Muted Revenues Despite A 29% Share Price Rise - 富途牛牛
Will QuidelOrtho's (QDEL) Renewed Cost Discipline Strengthen Its Long-Term Growth Story? - simplywall.st
Why QuidelOrtho (QDEL) is a Top Growth Stock for the Long-Term - Yahoo Finance
QuidelOrtho narrows China outlook to mid-single-digit growth as cost actions drive margin gains - MSN
QuidelOrtho’s Earnings Call: Mixed Sentiment with Global Growth - The Globe and Mail
QuidelOrtho Topped Estimates But Still Posted A Net Loss - Finimize
QuidelOrtho (QDEL) Analyst Rating Update: UBS Lowers Price Target | QDEL Stock News - GuruFocus
QuidelOrtho Stock Gains Following Q2 Earnings Beat, Margins Expand - MSN
UBS Cuts Price Target on QuidelOrtho to $26 From $29, Maintains Neutral Rating - MarketScreener
Should Value Investors Buy QuidelOrtho (QDEL) Stock? - Yahoo Finance
QuidelOrtho 2025 Q2 Earnings Widens Losses Amid Revenue Decline - AInvest
QuidelOrtho Corporation (NASDAQ:QDEL) Q2 2025 Earnings Call Transcript - Insider Monkey
QuidelOrtho Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
QuidelOrtho Q2 Revenue Beats Estimate, EPS Turns Positive Amid Restructuring Costs. - AInvest
QuidelOrtho Q2 2025 Earnings: Adjusted EPS Beats Estimates, Revenue Hits $614 Million - AInvest
Citigroup Reiterates Buy on QuidelOrtho, PT Lowered to $40 - AInvest
QuidelOrtho (QDEL) Fiscal Q2 EPS Beats - AOL.com
QuidelOrtho shares rise 14.02% premarket after reporting Q2 earnings with improved EBITDA margin and cost savings. - AInvest
QuidelOrtho Stock Soars 10.85% on Q2 Earnings Beat - AInvest
Citi Adjusts QuidelOrtho (QDEL) Price Target, Maintains Buy Rati - GuruFocus
QuidelOrtho 2025 Q2 Earnings Deeper Losses Amid Revenue Decline - AInvest
QuidelOrtho revenue decreases to USD 614M in Q2 2025 - Medical Buyer
QuidelOrtho: Q2 Earnings Snapshot - Huron Daily Tribune
QuidelOrtho Corp SEC 10-Q Report - TradingView
QuidelOrtho's Q2 Financial Performance and Future OutlookNews and Statistics - IndexBox
QuidelOrtho's Strategic Cost-Cutting and Margin Expansion: A Hidden Opportunity in a Declining Revenue Environment? - AInvest
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):